 | • レポートコード：TPM-B04413 • 出版社/出版日：Transparency Market Research / 2018年2月 • レポート形態：英文、PDF、222ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、体外診断の世界市場について調べ、体外診断の世界規模、市場動向、市場環境、技術別分析、用途別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・体外診断の世界市場動向 ・体外診断の世界市場環境 ・体外診断の世界市場規模 ・体外診断の世界市場規模：技術別 ・体外診断の世界市場規模：用途別 ・体外診断の世界市場規模：エンドユーザー別 ・体外診断の世界市場：地域別市場規模・分析 ・体外診断の北米市場規模・予測 ・体外診断のアメリカ市場規模・予測 ・体外診断の中南米市場規模・予測 ・体外診断のヨーロッパ市場規模・予測 ・体外診断のアジア市場規模・予測 ・体外診断の日本市場規模・予測 ・体外診断の中国市場規模・予測 ・体外診断のインド市場規模・予測 ・体外診断の中東市場規模・予測 ・体外診断のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global In Vitro Diagnostics Market: Overview
This report on in vitro diagnostics market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing in vitro diagnostics products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global in vitro diagnostics market with respect to the leading market segments based on major types, applications, end users, and geographies.
Global In Vitro Diagnostics Market: Key Segments
By technology type market further segmented into point of care, molecular diagnostics, immunoassays, clinical chemistry, whole blood glucose monitoring, hematology, clinical microbiology, coagulation and hemostasis, and others. On the basis of applications in vitro diagnostics market has been segmented as drug testing, infectious disease, oncology, metabolic disease, autoimmune disease, and others. Further the market has been segmented according to its end users that includes diagnostics laboratories, hospitals, academic & research centers, home care and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing adoption rate worldwide, and technological advancement, in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the in vitro diagnostics market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global in vitro diagnostics market.
Global In Vitro Diagnostics Market: Regional Outlook
Geographically, in vitro diagnostics market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, market strategy overview, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global In Vitro Diagnostics Market.
Companies Mentioned in Report
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global In Vitro Diagnostics Market. The key players operating in the in vitro diagnostics market are Abbott., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Gen-Probe Incorporated, Ortho Clinical Diagnostics, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers (a division of Siemens AG), Sysmex Corporation, Qiagen N.V., Diasorin and Thermo Fisher Scientific Corporation. The global in vitro diagnostics market is dominated only by few players such as F. Hoffmann-La Roche Ltd and Abbott that operates global market.
The global In Vitro Diagnostics Market is segmented as follows:
Global In Vitro Diagnostics Market, by Technology
Point of Care
Molecular Diagnostics
Polymerase Chain Reaction(PCR)
Isothermal Nucleic Acid Amplification Technology
Microarray
Hybridization
DNA Sequencing and Next Generation Sequencing
Other MDX Technologies
Immunoassay
Enzyme-Linked Immunosorbent Assays (ELISA)
Radioimmunoassay (RIA)
Enzyme-Linked Immunospot (ELIspot) Assay
Rapid Tests
Other Immunoassay Techniques
Clinical Chemistry
Basic Metabolic Profile
Electrolyte Panel
Liver Panel
Lipid Panel
Renal Panel
Thyroid Function Panel
Specialty Chemical Tests
Whole Blood Glucose Monitoring
Hematology
Clinical Microbiology
Coagulation and Hemostasis
Others
Global In Vitro Diagnostics Market, by Application
Drug Testing
Infectious Disease
Oncology
Metabolic Disease
Autoimmune Disease
Others
Global In Vitro Diagnostics Market, by End User
Diagnostics Laboratories
Hospitals
Academic & Research Centers
Home Care
Others
Global In Vitro Diagnostics Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of the Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Product Overview
4.2. Key Industry Developments
4.3. Global In Vitro Diagnostics Market Size (US$ Mn) Forecast
4.4. Market Opportunity Map
4.5. Porter’s Analysis
4.6. Global In Vitro Diagnostics Market Outlook
4.7. Key Mergers and Acquisition
4.8. Key Success Factor for Top 3 Players
4.9. Regulatory Scenario
4.10. Technology Assessment
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunity Analysis
5.5. Opportunities
6. Global In Vitro Diagnostics Market Analysis By Technology Type
6.1. Key Findings
6.2. Introduction
6.3. Global In Vitro Diagnostic Market Value Share Analysis, by Technology Type
6.4. Global In Vitro Diagnostic Market Forecast, by Technology Type
6.4.1. Point of Care
6.4.2. Molecular Diagnostics
6.4.2.1. Polymerase Chain Reaction (PCR)
6.4.2.2. Isothermal Nucleic Acid Amplification Technology
6.4.2.3. Microarray
6.4.2.4. Hybridization
6.4.2.5. DNA Sequencing and Next Generation Sequencing
6.4.2.6. Other MDx Technologies
6.4.3. Immunoassays
6.4.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
6.4.3.2. Radioimmunoassay (RIA)
6.4.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
6.4.3.4. Rapid Tests
6.4.3.5. Other Immunoassay Techniques
6.4.4. Clinical Chemistry
6.4.4.1. Basic Metabolite
6.4.4.2. Electrolyte Panel
6.4.4.3. Liver Panel
6.4.4.4. Lipid Panel
6.4.4.5. Renal Panel
6.4.4.6. Thyroid Function
6.4.4.7. Specialty Chemical Tests
6.4.5. Whole Blood Glucose Monitoring
6.4.6. Hematology
6.4.7. Clinical Microbiology
6.4.8. Coagulation and Hemostasis
6.4.9. Others
6.5. Global In Vitro Diagnostics Market Analysis By Technology Type
6.6. Global In Vitro Diagnostics Market Attractiveness Analysis By Technology Type
6.7. Key Trends
7. Global In Vitro Diagnostic Market Analysis, by Application
7.1. Key Findings
7.2. Introduction
7.3. Global In Vitro Diagnostic Market Value Share Analysis, by Application
7.4. Global In Vitro Diagnostic Market Forecast, by Application
7.4.1. Drug testing
7.4.2. Infectious Disease
7.4.3. Oncology
7.4.4. Metabolic Disease
7.4.5. Autoimmune Disease
7.4.6. Others
7.5. Global In Vitro Diagnostics Market Analysis by Application
7.6. Global In Vitro Diagnostic Market Attractiveness Analysis, by Application
7.7. Key Trends
8. Global In Vitro Diagnostic Market Analysis, by End Users
8.1. Key Findings
8.2. Introduction
8.3. Global In Vitro Diagnostic Market Value Share Analysis, by End Users
8.4. Global In Vitro Diagnostic Market Forecast, by End Users
8.4.1. Diagnostic Laboratories
8.4.2. Hospitals
8.4.3. Academic & Research Centers
8.4.4. Home Care
8.4.5. Others
8.5. Global In Vitro Diagnostic Market Analysis, by End Users
8.6. Global In Vitro Diagnostic Market Attractiveness Analysis, by End Users
8.7. Key Trends
9. Global In Vitro Diagnostics Market Analysis, by Region
9.1. Global In Vitro Diagnostic Market Scenario
9.2. Global In Vitro Diagnostics Market Value Share Analysis, by Region, 2016 and 2025
9.3. Global In Vitro Diagnostics Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global In Vitro Diagnostics Market Attractiveness Analysis, by Region, 2017–2025
10. North America In Vitro Diagnostic Market Analysis
10.1. Key Findings
10.2. North America In Vitro Diagnostic Market Overview
10.3. North America In Vitro Diagnostic Market Value Share Analysis, by Country
10.4. North America In Vitro Diagnostic Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. North America In Vitro Diagnostic Market Value Share Analysis, by technology Type
10.6. North America In Vitro Diagnostic Market Forecast, by Technology Type
10.6.1. Point of Care
10.6.2. Molecular Diagnostics
10.6.2.1. Polymerase Chain Reaction (PCR)
10.6.2.2. Isothermal Nucleic Acid Amplification Technology
10.6.2.3. Microarray
10.6.2.4. Hybridization
10.6.2.5. DNA Sequencing and Next Generation Sequencing
10.6.2.6. Other MDx Technologies
10.6.3. Immunoassays
10.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
10.6.3.2. Radioimmunoassay (RIA)
10.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
10.6.3.4. Rapid Tests
10.6.3.5. Other Immunoassay Techniques
10.6.4. Clinical Chemistry
10.6.4.1. Basic Metabolite
10.6.4.2. Electrolyte Panel
10.6.4.3. Liver Panel
10.6.4.4. Lipid Panel
10.6.4.5. Renal Panel
10.6.4.6. Thyroid Function
10.6.4.7. Specialty Chemical Tests
10.6.5. Whole Blood Glucose Monitoring
10.6.6. Hematology
10.6.7. Clinical Microbiology
10.6.8. Coagulation and Hemostasis
10.6.9. Others
10.7. North America In Vitro Diagnostic Market Value Share Analysis, by Application
10.8. North America In Vitro Diagnostic Market Forecast, by Application
10.8.1. Drug testing
10.8.2. Infectious Disease
10.8.3. Oncology
10.8.4. Metabolic Disease
10.8.5. Autoimmune Disease
10.8.6. Others
10.9. North America In Vitro Diagnostic Market Value Share Analysis, by End User
10.10. North America In Vitro Diagnostic Market Forecast, by End User
10.10.1. Diagnostic Laboratories
10.10.2. Hospitals
10.10.3. Academic & Research Centers
10.10.4. Home Care
10.10.5. Others
10.11. Market Trends
11. Europe In Vitro Diagnostic Market Analysis
11.1. Key Findings
11.2. Europe In Vitro Diagnostic Market Overview
11.3. Europe In Vitro Diagnostic Market Value Share Analysis, by Country
11.4. Europe In Vitro Diagnostic Market Forecast, by Country
11.4.1. UK
11.4.2. Spain
11.4.3. Germany
11.4.4. Italy
11.4.5. France
11.4.6. Rest of Europe
11.5. Europe In Vitro Diagnostic Market Value Share Analysis, by Technology Type
11.6. Europe In Vitro Diagnostic Market Forecast, by Technology Type
11.6.1. Point of Care
11.6.2. Molecular Diagnostics
11.6.2.1. Polymerase Chain Reaction (PCR)
11.6.2.2. Isothermal Nucleic Acid Amplification Technology
11.6.2.3. Microarray
11.6.2.4. Hybridization
11.6.2.5. DNA Sequencing and Next Generation Sequencing
11.6.2.6. Other MDx Technologies
11.6.3. Immunoassays
11.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
11.6.3.2. Radioimmunoassay (RIA)
11.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
11.6.3.4. Rapid Tests
11.6.3.5. Other Immunoassay Techniques
11.6.4. Clinical Chemistry
11.6.4.1. Basic Metabolite
11.6.4.2. Electrolyte Panel
11.6.4.3. Liver Panel
11.6.4.4. Lipid Panel
11.6.4.5. Renal Panel
11.6.4.6. Thyroid Function
11.6.4.7. Specialty Chemical Tests
11.6.5. Whole Blood Glucose Monitoring
11.6.6. Hematology
11.6.7. Clinical Microbiology
11.6.8. Coagulation and Hemostasis
11.6.9. Others
11.7. Europe In Vitro Diagnostic Market Value Share Analysis, by Application
11.8. Europe In Vitro Diagnostic Market Forecast, by Application
11.8.1. Drug testing
11.8.2. Infectious Disease
11.8.3. Oncology
11.8.4. Metabolic Disease
11.8.5. Autoimmune Disease
11.8.6. Others
11.9. Europe In Vitro Diagnostic Market Value Share Analysis, by End User
11.10. Europe In Vitro Diagnostic Market Forecast, by End User
11.10.1. Diagnostic Laboratories
11.10.2. Hospitals
11.10.3. Academic & Research Centers
11.10.4. Home Care
11.10.5. Others
11.11. Market Trends
12. Asia Pacific In Vitro Diagnostic Market Analysis
12.1. Key Findings
12.2. Asia Pacific In Vitro Diagnostic Market Overview
12.3. Asia Pacific In Vitro Diagnostic Market Value Share Analysis, by Country
12.3.1. India
12.3.2. China
12.3.3. Japan
12.3.4. Australia and New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific In Vitro Diagnostic Market Forecast, by Country
12.5. Asia Pacific In Vitro Diagnostic Market Value Share Analysis, by Technology Type
12.6. Asia Pacific In Vitro Diagnostic Market Forecast, by Technology Type
12.6.1. Point of Care
12.6.2. Molecular Diagnostics
12.6.2.1. Polymerase Chain Reaction (PCR)
12.6.2.2. Isothermal Nucleic Acid Amplification Technology
12.6.2.3. Microarray
12.6.2.4. Hybridization
12.6.2.5. DNA Sequencing and Next Generation Sequencing
12.6.2.6. Other MDx Technologies
12.6.3. Immunoassays
12.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
12.6.3.2. Radioimmunoassay (RIA)
12.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
12.6.3.4. Rapid Tests
12.6.3.5. Other Immunoassay Techniques
12.6.4. Clinical Chemistry
12.6.4.1. Basic Metabolite
12.6.4.2. Electrolyte Panel
12.6.4.3. Liver Panel
12.6.4.4. Lipid Panel
12.6.4.5. Renal Panel
12.6.4.6. Thyroid Function
12.6.4.7. Specialty Chemical Tests
12.6.5. Whole Blood Glucose Monitoring
12.6.6. Hematology
12.6.7. Clinical Microbiology
12.6.8. Coagulation and Hemostasis
12.6.9. Others
12.7. Asia Pacific In Vitro Diagnostic Market Value Share Analysis, by Application
12.8. Asia Pacific In Vitro Diagnostic Market Forecast, by Application
12.8.1. Drug testing
12.8.2. Infectious Disease
12.8.3. Oncology
12.8.4. Metabolic Disease
12.8.5. Autoimmune Disease
12.8.6. Others
12.9. Asia Pacific In Vitro Diagnostic Market Value Share Analysis, by End User
12.10. Asia Pacific In Vitro Diagnostic Market Forecast, by End User
12.10.1. Diagnostic Laboratories
12.10.2. Hospitals
12.10.3. Academic & Research Centers
12.10.4. Home Care
12.10.5. Others
12.11. Market Trends
13. Latin America In Vitro Diagnostic Market Analysis
13.1. Key Findings
13.2. Latin America In Vitro Diagnostic Market Overview
13.3. Latin America In Vitro Diagnostic Market Value Share Analysis, by Country
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America In Vitro Diagnostic Market Forecast, by Country
13.5. Latin America In Vitro Diagnostic Market Value Share Analysis, by technology Type
13.6. Latin America In Vitro Diagnostic Market Forecast, by Technology Type
13.6.1. Point of Care
13.6.2. Molecular Diagnostics
13.6.2.1. Polymerase Chain Reaction (PCR)
13.6.2.2. Isothermal Nucleic Acid Amplification Technology
13.6.2.3. Microarray
13.6.2.4. Hybridization
13.6.2.5. DNA Sequencing and Next Generation Sequencing
13.6.2.6. Other MDx Technologies
13.6.3. Immunoassays
13.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
13.6.3.2. Radioimmunoassay (RIA)
13.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
13.6.3.4. Rapid Tests
13.6.3.5. Other Immunoassay Techniques
13.6.4. Clinical Chemistry
13.6.4.1. Basic Metabolite
13.6.4.2. Electrolyte Panel
13.6.4.3. Liver Panel
13.6.4.4. Lipid Panel
13.6.4.5. Renal Panel
13.6.4.6. Thyroid Function
13.6.4.7. Specialty Chemical Tests
13.6.5. Whole Blood Glucose Monitoring
13.6.6. Hematology
13.6.7. Clinical Microbiology
13.6.8. Coagulation and Hemostasis
13.6.9. Others
13.7. Latin America In Vitro Diagnostic Market Value Share Analysis, by Application
13.8. Latin America In Vitro Diagnostic Market Forecast, by Application
13.8.1. Drug testing
13.8.2. Infectious Disease
13.8.3. Oncology
13.8.4. Metabolic Disease
13.8.5. Autoimmune Disease
13.8.6. Others
13.9. Latin America In Vitro Diagnostic Market Value Share Analysis, by End User
13.10. Latin America In Vitro Diagnostic Market Forecast, by End User
13.10.1. Diagnostic Laboratories
13.10.2. Hospitals
13.10.3. Academic & Research Centers
13.10.4. Home Care
13.10.5. Others
13.11. Market Trends
14. Middle East & Africa In Vitro Diagnostic Market Analysis
14.1. Key Findings
14.2. Middle East & Africa In Vitro Diagnostic Market Overview
14.3. Middle East & Africa In Vitro Diagnostic Market Value Share Analysis, by Country
14.3.1. South Africa
14.3.2. GCC
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa In Vitro Diagnostic Market Forecast, by Country
14.5. Middle East & Africa In Vitro Diagnostic Market Value Share Analysis, by Technology Type
14.6. Middle East & Africa In Vitro Diagnostic Market Forecast, by Technology Type
14.6.1. Point of Care
14.6.2. Molecular Diagnostics
14.6.2.1. Polymerase Chain Reaction (PCR)
14.6.2.2. Isothermal Nucleic Acid Amplification Technology
14.6.2.3. Microarray
14.6.2.4. Hybridization
14.6.2.5. DNA Sequencing and Next Generation Sequencing
14.6.2.6. Other MDx Technologies
14.6.3. Immunoassays
14.6.3.1. Enzyme-Linked Immunosorbent Assays (ELISA)
14.6.3.2. Radioimmunoassay (RIA)
14.6.3.3. Enzyme-Linked Immunospot (ELIspot) Assay
14.6.3.4. Rapid Tests
14.6.3.5. Other Immunoassay Techniques
14.6.4. Clinical Chemistry
14.6.4.1. Basic Metabolite
14.6.4.2. Electrolyte Panel
14.6.4.3. Liver Panel
14.6.4.4. Lipid Panel
14.6.4.5. Renal Panel
14.6.4.6. Thyroid Function
14.6.4.7. Specialty Chemical Tests
14.6.5. Whole Blood Glucose Monitoring
14.6.6. Hematology
14.6.7. Clinical Microbiology
14.6.8. Coagulation and Hemostasis
14.6.9. Others
14.7. Middle East & Africa In Vitro Diagnostic Market Value Share Analysis, by Application
14.8. Middle East & Africa In Vitro Diagnostic Market Forecast, by Application
14.8.1. Drug testing
14.8.2. Infectious Disease
14.8.3. Oncology
14.8.4. Metabolic Disease
14.8.5. Autoimmune Disease
14.8.6. Others
14.9. Middle East & Africa In Vitro Diagnostic Market Value Share Analysis, by End User
14.10. Middle East & Africa In Vitro Diagnostic Market Forecast, by End User
14.10.1. Diagnostic Laboratories
14.10.2. Hospitals
14.10.3. Academic & Research Centers
14.10.4. Home Care
14.10.5. Others
14.11. Market Trends
15. Company Profiles
15.1. Competition Matrix
15.2. In Vitro Diagnostics Market Share Analysis, by Company, 2016 (Estimated)
15.2.1. F. Hoffmann-La Roche Ltd.
15.2.1.1. Company Details
15.2.1.2. Business Overview
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Danaher
15.2.2.1. Company Details
15.2.2.2. Business Overview
15.2.2.3. Financial Overview
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Siemens Healthineers
15.2.3.1. Company Details
15.2.3.2. Business Overview
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4. bioMérieux SA
15.2.4.1. Company Details
15.2.4.2. Business Overview
15.2.4.3. Strategic Overview
15.2.4.4. SWOT Analysis
15.2.5. Abbott
15.2.5.1. Company Details
15.2.5.2. Business Overview
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Diasorin
15.2.6.1. Company Details
15.2.6.2. Business Overview
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. Meridian Bioscience, Inc
15.2.7.1. Company Details
15.2.7.2. Business Overview
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. Ortho-Clinical Diagnostics, Inc
15.2.8.1. Company Details
15.2.8.2. Business Overview
15.2.8.3. Strategic Overview
15.2.8.4. SWOT Analysis
15.2.9. Thermo Fisher Scientific, Inc.
15.2.9.1. Company Details
15.2.9.2. Business Overview
15.2.9.3. Strategic Overview
15.2.9.4. SWOT Analysis
15.2.10. Sysmex Corporation
15.2.10.1. Company Details
15.2.10.2. Business Overview
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis
15.4. Other Prominent Players
Table 01: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 02: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Molecular Diagnostics, 2015–2025
Table 03: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Immunoassays, 2015–2025
Table 04: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Clinical Chemistry, 2015–2025
Table 05: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 06: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 06: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 07: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country 2015–2025
Table 08: North America In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 09: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Molecular Diagnostics, 2015–2025
Table 10: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Immunoassays, 2015–2025
Table 11: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Clinical Chemistry, 2015–2025
Table 12: North America In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2015–2025
Table 13: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 14: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2015–2025
Table 15: Europe In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 16: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Molecular Diagnostics, 2015–2025
Table 17: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Immunoassays, 2015–2025
Table 18: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Clinical Chemistry, 2015–2025
Table 19: Europe In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2015–2025
Table 20: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 21: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2015–2025
Table 22: Asia Pacific In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 23: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Molecular Diagnostics, 2015–2025
Table 24: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Immunoassays, 2015–2025
Table 25: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Clinical Chemistry, 2015–2025
Table 26: Asia Pacific In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2015–2025
Table 27: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 28: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2015–2025
Table 29: Latin America In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 30: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Molecular Diagnostics, 2015–2025
Table 31: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Immunoassays, 2015–2025
Table 32: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Clinical Chemistry, 2015–2025
Table 33: Latin America In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2015–2025
Table 34: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 35: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2015–2025
Table 36: Middle East & Africa In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 37: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Molecular Diagnostics, 2015–2025
Table 38: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Immunoassays, 2015–2025
Table 39: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Technology Type-Clinical Chemistry, 2015–2025
Table 40: Middle East & Africa In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2015–2025
Table 41: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End User, 2015–2025